Le Lézard
Classified in: Health, Business
Subject: CXP

New Ann Arbor Fitness Studio Offers Unrivaled Fitness Experience


ANN ARBOR, Mich., June 21, 2018 /PRNewswire/ -- SPENGA, a workout studio that combines spin, strength and yoga in one 60-minute session, is pleased to announce the opening of its newest location in Ann Arbor, Michigan.

Each studio has experienced instructors that guide members through a 60-minute workout unlike anything else. While most studios focus on one type of workout, SPENGA combines:

This one-hour workout boosts endurance, strengthens muscles and restores the body for the most efficient workout possible. SPENGA is ideal for anyone who wants to get a well-rounded and convenient workout all at one studio.

"We are thrilled to be opening our first SPENGA studio in Michigan," Roger McGreal, SPENGA Co-Founder. "Ann Arbor is such an incredible area and we are so excited to be part of the amazing atmosphere and energy."

SPENGA offers sessions daily starting at 5:00 am - 8:00pm and prices will range from $69 per month for 4X-per month to $149 per month for unlimited sessions. For exclusive membership rates call the studio at 734-666-8207 or stop by for a personalized tour.

The studio is scheduled to open June 25th.

SPENGA of Ann Arbor is located at 859 W. Eisenhower Parkway, Ann Arbor, MI 48103.

About SPENGA
Crafted by a group of fitness professionals, SPENGA (spin, strength, yoga) combines three essential elements of fitness to create the best workout ever. Each 60-minute session boosts endurance, strengthens muscles and restores the body through a combination of spin, HIIT training and yoga. SPENGA currently has eight studios throughout the US. To learn more about SPENGA, visit SPENGA.com or facebook.com/SPENGAfitness.

Roger McGreal
Co-Founder
773-550-6735 
[email protected]

 

SOURCE SPENGA


These press releases may also interest you

at 16:05
BeiGene, Ltd. , a global oncology company, today announced it will share research outcomes from its broad hematology and solid tumor portfolio at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, May 31 - June 4, 2024....

at 16:05
Mundipharma* today announced the acquisition of all assets and rights related to rezafungin globally from Cidara Therapeutics. This provides Mundipharma with global ownership of rezafungin including ongoing development and distribution. Rezafungin...

at 16:05
Arrowhead Pharmaceuticals, Inc. today announced that it will host a webcast and conference call on May 9, 2024, at 4:30 p.m. ET to discuss its financial results for the fiscal second quarter ended March 31, 2024. Webcast and Conference Call and...

at 16:05
Arcus Biosciences, Inc. , a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, today announced three accepted abstracts at the 2024 American Society of...

at 16:03
First Quarter 2024 Total Revenues of $649 Million (+9% Y/Y and +13% at Constant Currency Y/Y); GAAP Diluted Earnings per Share (EPS) of $0.46 (+70% Y/Y) and Non-GAAP Diluted Earnings per Share of $0.71 (+18% Y/Y) VOXZOGO® Net Product Revenues of $153...

at 16:01
Karyopharm Therapeutics Inc. , a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that several abstracts detailing new selinexor data have been selected for presentation at the 2024 American Society of...



News published on and distributed by: